[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$BMNR $MSFT $CRWV $HIMS $TSSI $RKLB $BJDX $TTRX $AMBO $EPWK $RGTI $BAOS $BABA $DGNX $GLDG $VNTG $RBNE $RDDT $HOOD $NIO $CRCW $ADAP $HIVE $TSM $RXRX $ONDS $BIDU $BBAI $PLUG $AMPX $LCID $CRWD $BZAI $POET $SOUN $CIFR $CLF $WOLF $TELO $BMNR $GOOGL $RCAT $NVDA $TSLA $AAPL "
X Link @Specialpstock 2025-10-16T19:37Z XXX followers, XXX engagements
"$CTXR - Citius Pharmaceuticals (NASDAQ: CTXR) Eyes $400M Market Opportunity with LYMPHIR Launch $ABCL $ABCM $ABEO $ABIO $ABUS $ACET $ACMR $ACRX $ADAG $ACIU $ADAP $AEZS $AFMD $AGRX $AKBA $AKRO $AKTX $ALDX $ALNY $AKAM $AMGN $AMRN $ANIK $APLS $APLT $AXVXL $AVIR $CARA $CELC $CELH $MNKD $BTAI $BNRX $BNTC $CRIS $CRSP $CYCC $CGTX $CYAD $CTXR $CSBR $ELVVN $EQRX $DRRX $GOVX $GTRS"
X Link @Specialpstock 2025-10-16T12:09Z XXX followers, 1856 engagements
"$OMER signed a definitive agreement to sell global rights of its MASP-3 inhibitor zaltenibart (OMS906) to Novo Nordisk for $340M upfront and near-term milestones with total deal value up to $2.1B plus tiered royalties giving Novo full control over development and commercialization in rare blood and kidney disorders. $GNPX $OMER $SPRC $EVAX $ENVB $SBFM $TOVX $SANA $AKTX $GANX See More Biotech Updates👇"
X Link @BPharmCatalyst 2025-10-15T20:34Z 30.4K followers, 2073 engagements
"Akari Therapeutics ($AKTX) Announces $2.5M Registered Direct Offering"
Reddit Link @Educational_Cup9809 2025-10-15T18:47Z X followers, X engagements